alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### The People of the State of New York, Respondent, v Randy Sears Watson, Appellant.

Judgment unanimously affirmed. Memorandum: The suppression court properly denied defendant’s motion to suppress the statement he made to the police. We find no basis to disturb the court’s finding that defendant was not in custody when the statement was made.

Contrary to defendant’s contention, the trial court did not erroneously preclude defense counsel from impeaching a prosecution witness by inquiring into prior bad acts. The court properly sustained the objection to defense counsel’s question whether the witness was fired because his employer felt that he had been stealing from the cash register. What the employer felt is not competent proof of a bad act. The court properly exercised its discretion in precluding inquiry into a prior conviction for disorderly conduct because, in its opinion, that violation was not probative of the witness’s credibility *(see, People v King,*141 AD2d 563, *lv denied*72 NY2d 958; *People v Morales,*135 AD2d 742, *lv denied*71 NY2d 900). *955Objections to other questions were sustained because the questions were in improper form.

Lastly, the trial court was justified in denying defendant’s motion to set aside the verdict on the grounds of newly discovered evidence because, after a hearing, it found that the newly discovered evidence was not believable *(see, People v Penoyer,*72 NY2d 936). (Appeal from judgment of Monroe County Court, Wisner, J. — robbery, first degree, and other charges.) Present — Doerr, J. P., Denman, Boomer, Balio and Lawton, JJ.
[Federal Register Volume 66, Number 88 (Monday, May 7, 2001)]
[Notices]
[Page 23036]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-11397]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Initial Review Group, Biomedical Research and Research 
Training Review Subcommittee B.
    Date: June 13, 2001.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Carole H. Latker, PhD, Scientific Review 
Administrator, Office of Scientific Review, National Institute of 
General Medical Sciences, National Institutes of Health, Natcher 
Building Room 1AS-13, Bethesda, MD 20892, (301) 594-3663.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93,96, 
Special Minority Initiatives, National Institutes of Health, HHS)

    Dated: April 30, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-11397 Filed 5-4-01; 8:45 am]
BILLING CODE 4140-01-M
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 778 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 778

  To authorize the interstate traffic of unpasteurized milk and milk 
        products that are packaged for direct human consumption.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 28, 2009

   Mr. Paul introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
  To authorize the interstate traffic of unpasteurized milk and milk 
        products that are packaged for direct human consumption.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. INTERSTATE TRAFFIC OF UNPASTEURIZED MILK AND MILK PRODUCTS.

    (a) Sale Allowed.--Notwithstanding the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 301 et seq.) and section 361 of the Public 
Health Service Act (42 U.S.C. 264), and any regulations or other 
guidance issued thereunder, a Federal department, agency, or court may 
not take any action (administrative, civil, criminal, or otherwise) 
that would prohibit, interfere with, regulate, or otherwise restrict 
the interstate traffic of milk, or a milk product, that is 
unpasteurized and packaged for direct human consumption solely on the 
basis that the milk or milk product is unpasteurized and is therefore 
adulterated, misbranded, or otherwise in violation of Federal law.
    (b) Definitions.--In this section, the following definitions apply:
            (1) The terms ``interstate traffic'', ``milk'', and ``milk 
        products'' have the meanings given those terms in section 
        1240.3 of title 21, Code of Federal Regulations (as in effect 
        on the date of enactment of this Act).
            (2) The term ``packaged for direct human consumption'' 
        means milk and milk products that are packaged for the final 
        consumer and intended for human consumption. Such term does not 
        include milk and milk products that are packaged for additional 
        processing, including pasteurization, before being consumed by 
        humans.
            (3) The term ``pasteurized'' means the process of heating 
        milk and milk products to the applicable temperature specified 
        in the tables contained in section 1240.61 of title 21, Code of 
        Federal Regulations (or successor regulations), and held 
        continuously at or above that temperature for at least the 
        corresponding specified time in such tables.
                                 <all>
```
Case 1:07-cv-04511-AKH Document 7 Filed 08/07/2007 Page 1 of 1
Clear All

        08 September 2023    

                    U.S. Navy and Marines arrive in Latvia for the upcoming German Baltic Sea exercise Northern Coast 2023                 
                The San Antonio-class amphibious transport dock USS Mesa Verde (LPD 19) and embarked 26th Marine Expeditionary Unit (Special Operations Capable) Bravo Command Element, arrived in Riga, Latvia for a routine and scheduled port visit, Sept. 7, 2023.            

        05 August 2023    

                    USS Mesa Verde (LPD-19) Arrives in Narvik, Norway                 
                USS Mesa Verde (LPD-19), assigned to the Bataan Amphibious Ready Group (ARG), and embarked 26th Marine Expeditionary Unit (MEU) Special Operations Capable (SOC), arrived in Narvik, Norway for a scheduled port visit to enhance the U.S.-Norway relationship and demonstrate our continued commitment to            

        29 July 2023    

                    USS Mesa Verde (LPD-19) and 26th Marine Expeditionary Unit (SOC) Arrives in the U.K.                 
                The San Antonio-class amphibious transport dock USS Mesa Verde (LPD-19), assigned to the Bataan Amphibious Ready Group (ARG), and the 26th Marine Expeditionary Unit (Special Operations Capable) (MEU(SOC)) arrived in Plymouth, U.K. for a regularly scheduled port visit, July 28.            

        22 September 2022    

                    UNITAS Concludes After Successful Exercise                 
                RIO DE JANEIRO - UNITAS LXIII (63), the world’s longest-running multinational maritime exercise concluded with a closing ceremony in Rio De Janeiro, Sept. 22, 2022.            

#####  

##### Navy.mil  |  Navy.com  |  Navy FOIA  |  DoD Accessibility/Section 508  |  No Fear Act  |  Open Government  |  Plain Writing Act USA.gov  |  Veterans Crisis Line  |  VA Vet Center  |  FVAP  |   DoD Safe Helpline  |  Navy SAPR  |  NCIS Tips  |  Privacy Policy  |  Site Map  |  Contact US

###### Commander, U.S. Fleet Forces Command   |   1562 Mitscher Ave., Suite 250   |   Norfolk, Virginia 23551-2487

###### Official U.S. Navy Website
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

CONSTANCE RAMOS,

Appellant,

v.

SALVATORE DECARO,

Appellee.

No. 4D20-2803

[November 10, 2021]

Appeal from the Circuit Court for the Fifteenth Judicial Circuit, Palm 

Beach County; Karen M. Miller, Judge; L.T. Case No. 50-2020-GA-000057-

XXXX-NB.

Emre Yersel and Martin G. McCarthy of McCarthy & Yersel, PLLC, 

Miami, for appellant.

Grace Mackey Streicher and Andrew A. Harris of Harris Appeals, P.A., 

Palm Beach Gardens, for appellee.

PER CURIAM.

Affirmed.

CONNER, C.J., MAY and DAMOORGIAN, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
Exhibit 32.2



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,



AS ADOPTED PURSUANT TO



SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the quarterly report on Form 10-Q of Tier Technologies, Inc. (the Company) for the quarter ended March 31, 2005, as
filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, David E. Fountain, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:



| | 1. | This Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended.
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------



|                      |  |                                           
|--------------------- |  | ------------------------------------------
|Dated: August 8, 2005 |  | /s/ David E. Fountain                     
|                      |  | David E. Fountain, Chief Financial Officer
[Federal Register Volume 66, Number 89 (Tuesday, May 8, 2001)]
[Notices]
[Page 23309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-11540]


=======================================================================
-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[Applicant No. 99000444]


First Capital Group of Texas III, L.P.; Notice Seeking Exemption 
Under Section 312 of the Small Business Investment Act, Conflicts of 
Interest

    Notice is hereby given that First Capital Group of Texas III, L.P., 
750 E. Mulberry, Suite 305, San Antonio, Texas 78212, an applicant for 
a Federal License under the Small Business Investment Act of 1958, as 
amended (``the Act''), in connection with the financing of a small 
concern, has sought an exemption under section 312 of the Act and 
section 107.730, Financings which Constitute Conflicts of Interest of 
the Small Business Administration (``SBA'') rules and regulations (13 
CFR 107.730 (2000)). First Capital Group of Texas III, L.P. proposes to 
provide equity/debt security financing to BEI Group, Inc.,1051 East 
Nakoma, San Antonio, Texas 78216. The financing is contemplated for the 
purpose of providing working capital.
    The financing is brought within the purview of Sec. 107.730(a)(1) 
of the Regulations because First Capital Group of Texas II, L.P., an 
Associate of First Capital Group of Texas III, L.P., currently owns 
greater than 10 percent of BEI Group, Inc. and therefore BEI Group, 
Inc. is considered an Associate of First Capital Group of Texas III, 
L.P. as defined in Sec. 107.50 of the SBA Regulations.
    Notice is hereby given that any interested person may submit 
written comments on the transaction to the Associate Administrator for 
Investment, U.S. Small Business Administration, 409 Third Street, SW, 
Washington, DC 20416.

    Dated: April 27, 2001.
Harry Haskins,
Acting Associate Administrator for Investment.
[FR Doc. 01-11540 Filed 5-7-01; 8:45 am]
BILLING CODE 8025-01-P
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 1 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 2 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 3 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 4 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 5 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 6 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 7 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 8 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 9 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 10 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 11 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 12 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 13 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 14 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 15 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 16 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 17 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 18 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 19 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 20 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 21 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 22 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 23 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 24 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 25 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 26 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 27 of 28
Case 1:07-cv-05717-SAS Document 1 Filed 06/15/2007 Page 28 of 28
#### The People of the State of New York, Respondent, v Gerald English, Appellant.

Appeal by the defendant from a judgment of the Supreme Court, Queens County (Leahy, J.), rendered March 18, 1985, convicting him of murder in the second degree and criminal possession of a weapon in the second degree, upon a jury verdict, and imposing sentence.

Ordered that the judgment is affirmed.

We have considered and rejected most of the issues raised by the defendant upon the appeal by his codefendant Ronnie *576Simpson with whom this defendant was jointly tried *(see, People v Simpson,*153 AD2d 596 [decided herewith]). The defendant has not raised any arguments requiring a different result. Mollen, P. J., Thompson, Lawrence and Eiber, JJ., concur.
[EXHIBIT 99.1]



                          CERTIFICATIONS

I, Paul Kravitz, certify that:

1.   I have reviewed this quarterly report on Form 10-QSB of Med Gen,
Inc.;

2. Based on my knowledge, this quarterly report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other
financial information included in this quarterly report, fairly
present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the
periods presented in this quarterly report;

Date:  May 19, 2003



                      By:_______/s/Paul B. Kravitz___________
                         Paul Kravitz
                         Chief Executive Officer


I, Jack Chien, certify that:

1.   I have reviewed this quarterly report on Form 10-QSB of Med Gen,
Inc.;

2. Based on my knowledge, this quarterly report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other
financial information included in this quarterly report, fairly
present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the
periods presented in this quarterly report;

Date:  May 19, 2003



                      By:__________/s/Jack Chien_____________
                         Jack Chien
                         Chief Financial Officer, and
                         Principal Accounting Officer
Case 1:07-cv-01656-AKH Document 12 Filed 02/06/2008 Page 1 of 3Case 1:07-cv-01656-AKH Document 12 Filed 02/06/2008 Page 2 of 3Case 1:07-cv-01656-AKH Document 12 Filed 02/06/2008 Page 3 of 3
Clear All

        21 August 2023    

                    USNS Burlington Arrives in Colombia                 
                SANTA MARTA, Colombia - The Spearhead-class expeditionary fast transport ship USNS Burlington (T-EPF 10) arrived in Santa Marta, Colombia on Aug. 20, marking the second stop throughout the course of the Continuing Promise 2023 mission.            

        02 August 2023    

                    U.S. 4th Fleet Announces Continuing Promise 2023 Deployment                 
                The U.S. Navy expeditionary fast transport USNS Burlington (T-EPF 10) will deploy to the U.S. Southern Command area of operations over the next two months as part of U.S. Naval Forces Southern Command/U.S. 4th Fleet’s Continuing Promise 2023 mission. Detailed planning has wrapped up for the            

        27 November 2022    

                    USNS COMFORT ARRIVES IN DOMINICAN REPUBLIC FOR CONTINUING PROMISE                 
                SANTO DOMINGO, Dominican Republic (Nov. 27, 2022) – Hospital ship USNS Comfort (T-AH 20) anchored off the coast of Santo Domingo, Dominican Republic in support of U.S. Naval Forces Southern Command/U.S. 4th Fleet’s Continuing Promise 2022 (CP22) mission, Nov. 27.The Comfort will hold subject matter            

        25 November 2022    

                     USNS COMFORT COMPLETES ITS THIRD MISSION STOP OF CP 2022 IN COLOMBIA                 
                CARTAGENA, Colombia (Nov. 20, 2022) U.S. Navy hospital ship USNS Comfort (T-AH 20) completed its third mission stop of Continuing Promise 2022 in Cartagena, Colombia, Nov. 20, 2022.During the ship’s nine-day visit to Colombia, Continuing Promise assisted over 4,400 patients from Cartagena and            

#####  

##### Navy.mil  |  Navy.com  |  Navy FOIA  |  DoD Accessibility/Section 508  |  No Fear Act  |  Open Government  |  Plain Writing Act USA.gov  |  Veterans Crisis Line  |  VA Vet Center  |  FVAP  |   DoD Safe Helpline  |  Navy SAPR  |  NCIS Tips  |  Privacy Policy  |  Site Map  |  Contact US

###### Commander, U.S. Fleet Forces Command   |   1562 Mitscher Ave., Suite 250   |   Norfolk, Virginia 23551-2487

###### Official U.S. Navy Website
Exhibit 31.2

SECTION 302 CERTIFICATION

I, Karl Brenza, Chief Financial Officer of enherent Corp., certify that:

1. I have reviewed this report on Form 10-Q of enherent Corp.;

2. Based on
my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being
prepared;

b) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal
quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and

5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of
registrants board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material
weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control
over financial reporting.



|                       
|-----------------------
|/s/ Karl Brenza        
|Karl Brenza            
|Chief Financial Officer
|                       
|May 10, 2007